Diabetes Resolution and Work Absenteeism After Gastric Bypass: a 6-Year Study by unknown
ORIGINAL CONTRIBUTIONS
Diabetes Resolution and Work Absenteeism After Gastric
Bypass: a 6-Year Study
E. Jönsson1 & P. Ornstein1,2 & H. Goine1,3 & J. L. Hedenbro4
# The Author(s) 2017. This article is published with open access at Springerlink.com
Abstract
Background Obesity-related diseases cause costs to society.
We studied the cost of work absenteeism before and after
gastric bypass and the effects of postoperative diabetes
resolution.
Patients and Methods Data were obtained from the
Scandinavian Obesity Surgery Registry (SOReg) (national
coverage >98%) and cross-matched with data from the Social
insurance Agency (coverage 100%) for the period ±3 years
from operation. In 2010, a total of 7454 bariatric surgeries were
performed; the study group is 4971 unique individuals with an
annual income of >10,750 Euros and complete data sets. A
sex-, age-, and income-matched reference population was iden-
tified for comparison.
Results Patients with obesity had preoperatively a 3.5-fold
higher absenteeism. During follow-up (FU), the ratio relative
to the reference population remained constant. An increase of
12–14 net absenteeism days was observed in the first 3 months
after surgery. Female sex (OR 1.5, CI 1.13–1.8), preoperative
anti-depressant use (OR 1.5, CI 1.3–1.9), low income (OR 1.4,
CI 1.2–1.8), and a history of sick leave (OR 1.004, CI 1.003–
1.004) were associated with increased absenteeism during FU.
Diabetes resolution did not decrease absenteeism from preop-
erative values.
Conclusions Patients with obesity have higher preoperative
absenteeism than the reference population. Operation caused
an increase the first 90 days after surgery of 12–13 days. There
were no relative increases in absenteeism in the next 3 years;
patients did not deviate from preoperative patterns but follow-
ed the trend of the reference population. Preoperative diabetes
did not elevate that level during FU; diabetes resolution did
not lower absenteeism.
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Background
The beneficial effects to patients of gastric bypass surgery
(RYGB) are well documented for quality of life [1], for reso-
lution of comorbidities [2, 3], for some cancer forms [4], and
also for mortality [5], particularly for diabetics [6]. Also, the
direct and indirect costs of the operation per quality-adjusted
life year (QUALY) have been estimated to be low and after
>15 years lead to reduced societal cost [7]. But some studies
suggest that RYGB may also induce problems and thus costs
to health care providers. Recently, emphasis has been given to
the problem of internal herniation, where between 2 and 10%
of patients have been reported to undergo a second operation
[8, 9]. Also, an increased risk of hospitalization for alcohol-
related disease has been suggested for gastric bypass patients
[10]. When considering costs, absenteeism due to such com-
plications must then be weighed against the beneficial effect
on comorbidities of the surgery. By using crude absenteeism
data, regardless of cause, the aim of the present study was to
examine whether surgery gave increased societal absenteeism
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costs or whether surgery by causing the disappearance of co-
morbidity led to a reduction in absenteeism.
Patients and Methods
Registries Sweden has national registries using unique
individual-specific identification numbers. The Scandinavian
Obesity Surgery Registry (SOReg) is fully comprehensive
and covers all operations, regardless of hospital and financing
[11]. It covers >98 of all bariatric surgery performed and its
database now comprises over 53,000 operations. Pre- and
postoperative comorbidities, operative and postoperative
complications, and basic data are registered, and the database
has recently been validated [12]. The operational definitions
in SOReg are such that a comorbidity exists if it renders a
patient to be on continuous physician-prescribed medication.
For type 2 diabetes (T2D), also non-medicated patients with a
baseline HbA1c >48 mmol/mol are included (corresponding
to ≥6.5%). The variable is thus dichotomous. Resolution of
T2D is also dichotomous and defined in SOReg as the com-
bination of a normal HbA1c and no ongoing medication.
Information on absenteeism and income was made available
through the Swedish Social Insurance Agency’s administra-
tive registries, covering 100% of the population. Individuals
with a pension-generating income are insured through this
agency, which reimburses work absenteeism from the third
week onwards, with the need for medical certification [13].
Patients All patients operated in Sweden with a primary
RYGB in 2010 were identified from the SOReg. This year
was chosen to permit a 3-year follow-up (FU) period and
allowing for up to 1 year delay in database management.
This cohort of patients was then cross-matched for each
individual with the database of the Swedish Social Insurance
Agency. Patients having had only a revisional operation in
2010 were excluded. Absenteeism was measured using the
amounts of reimbursement from the Social Insurance
Agency, for insured individuals. The study group was thus
restricted to patients with access to social insurance, opera-
tionalized through the following characteristics in 2010: age
in the range 20–62 years, no disability pension, and a declared
income of >10,750 Euros. An overview of the cohort of op-
erated patients is given in Fig. 1.
Reference Population The reference population was created
from the Swedish Social Insurance Agency database through
age, sex, and income matching. It is based on individuals
living in Sweden during 2010 without disability pension and
with a declared income from employment of >10,750 Euros.
The match was made by identifying individuals with the same
age and sex and choosing the closest ten individuals in terms
of income. Any individual with the exact same age, sex, and
income was excluded from the reference population so that no
one from the operated population would be included in the
reference population.
Statistics The study database has been analyzed at the
Swedish Social insurance Agency, which is responsible for
official statistics regarding absenteeism reimbursements. All
analyses were conducted using the SAS Enterprise Guide ver-
sion 7.1. First, we measured the total number of days with any
sickness benefit, for each 3-month period starting 3 years be-
fore the date of surgery until 3 years postoperatively, i.e., a
total of 24 data points for each included operated individual
and for corresponding individuals in the reference group. To
quantify societal cost, the number of days with benefits was
multiplied with the actual percentage of absenteeism. Two
days with 50% absenteeism thus equals one net day; results
are expressed as such net days. This method measures, rather
than calculates, societal costs and is used by the Swedish
National Board of Health and Welfare [14].
The relative change, per 3-month period, was examined in
order to account for different levels of sick leave in the study
groups and the reference population. The reason for this is that
due to the large difference in preoperative absenteeism be-
tween the patient and reference population, a small general
percentage change in absenteeism would generate a large shift
in the absolute difference between the groups. Next, hetero-
geneity within the patient group was analyzed. Patient data
were stratified for income levels and for age and finally ac-
cording to the existence of any comorbidity, specifically of
type 2 diabetes (T2D). Absenteeism data for patients with
diabetes was further sub-classified for resolution or no resolu-
tion postoperatively. In addition, simple logistic regression
was performed for analyzing the risk of sick leave from
90 days to 3 years postoperatively.
Baseline data from both patients and the reference popula-
tion are presented in Table 1. The level for statistical signifi-
cance was set at p < 0.05.
Fig. 1 Patient cohort for analyses. T2D FU type 2 diabetes follow-up
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Results
A total of 7454 patients were identified from SOReg coded for
having undergone a bariatric procedure in 2010 at any
Swedish surgical department for a total population of 9.2 mil-
lion. The inclusion criteria restricted the patient database to
7195 (97%) unique individuals with complete data sets and
further to 4971 (67%) individuals who were eligible for sick-
ness insurance (Fig. 1). Basal morphometric data for excluded
and included patients as well as for the reference population
are given in Table 1. Matching for age, sex, and income
achieved balance for these characteristics between included
patients and the reference population. Among the operated
patients, excluded patients had a higher prevalence of T2D
(p < 0.05) and also a lower resolution rate (p < 0.001) com-
pared with the included patients. However, as subjects in this
group lack access to social insurance, their absenteeism is
non-distinguishable and its costs neither measurable nor a cost
to society.
Patients with obesity had a higher absenteeism throughout
the study period (Fig. 2). Both the patient cohort and the
reference population displayed similar patterns of absenteeism
over the 6 years studied (Fig. 3). Long-term relative differ-
ences between patients and the reference population were thus
consistent with preoperative differences. Women had higher
absenteeism compared to men, both in the study group and in
the reference population.
0–90 Days Postoperatively To capture direct effects of oper-
ation, we looked specifically at the immediate postoperative
period, however including a somewhat longer time span to
capture potential heterogeneity in direct complications. For
the whole patient study group, an increase over mean preop-
erative values of 12 net days (males) or 13 net days (females)
was observed for the 90 days after surgery. Further classifica-
tion showed no association between preoperative comorbidity
and the size of the increment; 12.9 net days of absenteeism if
no preoperative comorbidity (both sexes combined) whereas
the presence of comorbidity was associated with 12.6 net days
(n.s.).
30 Days to 3 Years Postoperatively To follow long-term
consequences, the immediate postoperative period was ex-
cluded. Simple logistic regression was used to study what
characterized those with more net sick leave during FU be-
tween 30 days and 3 years. Female sex (OR 1.5, CI 1.3–1.8),
preoperative anti-depressant use (OR 1.5, CI 1.3–1.8), low
income (OR 1.4 CI 1.2–1.8), and a preoperative history of
sick leave (per day: OR 1.004, CI 1.003–1.004) were associ-
ated with more sick leave in the FU period. The preoperative
presence of T2D did not predict any further increase in absen-
teeism (OR 1.2, CI 1.0–1.5) in the FU period.
Patients with preoperative comorbidity had more sick days
than those without, both pre- and postoperatively (Fig. 4).
There were no obvious quantitative or qualitative differences
between patients with diabetes and those with other types of
comorbidity. Further analysis of absenteeism for patients with
diabetes showed no differences in postoperative absenteeism
between those with and those without diabetes resolution at
the 1-year postoperative FU (Fig. 5).
Table 1 Demographics of
operated patient cohorts,
separated for those meeting or not
meeting the criteria for inclusion
in the study, and data for the
reference population. Reasons for
exclusion from study are given in
Fig. 1. Patient data are from time
of operation; data for reference
population from time of data
acquisition (mean (SE))
Operated patients, not
included in the study
due to insurance ineligibility
Operated patients,
included in the study
Reference
population
Number of subjects 2222 4971 49,710
Age
Female 41.9 (0.31) 40.4 (0.15) 40.5 (0.05)
Male 44.4 (0.66) 42.8 (0.27) 42.8 (0.10)
BMI
Female 43.0 (0.14) 42.3 (0.09) n.a.
Male 44.0 (0.30) 43.7 (0.17) n.a.
Waist circumference (cm)
Female 125.1 (0.33) 123.8 (0.23) n.a.
Male 138.4 (0.70) 138.0 (0.40) n.a.
Declared annual income, Euros
Female 10,318 (213.0) 28,394 (187.4) 28,393 (59.3)
Male 11,193 (508.2) 35,637 (514.8) 35,637 (162.7)
Pre-op prevalence of T2D 20.5% (0.8) 13.2% (0.5) n.a.




Bariatric surgery is well known to give health benefits [1–6].
Medical care is also obviously coupled to direct as well as
indirect costs, but it has been suggested that the cost per
quality-adjusted life year is low in bariatric surgery [7] and
that bariatric surgery may cause a long-term reduction in
societal costs [7]. The operation can lead to complications
but the cost of such complications is difficult to measure.
Treatment of complications or re-operative surgery is often
performed at other departments and may thus not be prop-
erly accounted for in any one-center surgical database.
Indirect costs are even harder to quantify accurately, even
though attempts have been made. A study attempting quan-
tification of the direct costs, regardless of caregiver, has
recently been launched, using other national registries in
Sweden http://www.sveus.se/publikationer/rapporter/
obesitaskirurgi. No study on the long-term indirect costs
caused by absenteeism has been reported.
Sweden is an ideal country to study indirect costs of
surgery, in this case absenteeism, since the databases for
obesity surgery and sickness benefits are national and have
full coverage [13, 15]. We used these databases to quantify
the indirect postoperative costs of absenteeism. The study
material is thus the cohort, and not a sample, of patients
operated in 2010 and with access to social insurance. This
year was chosen to allow for delays in 1 year FU as well as
for late data entering into the systems. It was thus possible to
identify all absenteeism from work leading to remuneration
from the insurance system. In addition, the design of our
registries enabled us to create an age-, sex-, and income-
matched reference population. The operationalization means
Fig. 2 Number of net reimbursed
absenteeism days per 3-month
period, −3 to +3 years from oper-
ation, separated for gender and
group
Fig. 3 Relative change of net
absenteeism in relation to the
corresponding quarter in year −3
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that specific medical complications were not measured, the
focus being on a cohort of RYGB patients with employment,
to ensure that large health problems (as well as large im-
provements in health) would be captured in terms of in-
creases or decreases in work absenteeism. The rarity of in-
complete cases and the use of only patients and controls
with income gave us robust data. Operated patients that
did not meet the inclusion criterion of employment-
generated income had a higher prevalence of T2D and also
a lower resolution rate. The present study has however its
focus on changes on societal costs induced by bariatric sur-
gery, and the excluded group’s lack of access to social in-
surance makes their possible absenteeism non-measurable
and of no cost to the insurance system. Furthermore, patients
unemployed before surgery but postoperatively gaining
employment could not be included in the study. This seems
to be less of a problem, since it has been reported that
bariatric surgery causes no shifts in the rate of employment
[16, 17].
Not only direct complications but also unwanted side ef-
fects to the operation could lead to increased societal costs.
Any severe consequence of bariatric surgery leading to absen-
teeism from work is thus reflected in a database of the present
design, regardless of its cause and regardless of at which level
the patient is treated, inpatient, outpatient, or in primary care.
For example, the recently observed complication of laparo-
scopic gastric bypass of internal herniation has an estimated
prevalence of between 2 and 10% of patients needing a reop-
eration [11, 18]. In addition, Östlund et al. [10] have reported
an increased incidence of hospitalization for alcohol-related
Fig. 4 Number of net
absenteeism days per 3-month
period, −3 to +3 years from oper-
ation, by pre-op health status
Fig. 5 Number of absenteeism
days per 3-month period, only
diabetics, by post-op diabetes
resolution
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disease after gastric bypass. Any such condition with its en-
suing absenteeism would be captured in a study of the present
design.
The SOReg database has clearly showed that most comor-
bidities are reduced following surgery-induced weight loss [2,
19]. The present study material shows a preoperative correla-
tion between the existence of comorbidities and higher levels
of absenteeism. Comorbidity was however not associatedwith
absenteeism in the immediate postoperative period nor was
there any tendency to indicate that the disappearance of co-
morbidity following surgery caused any reduction in
absenteeism.
Due to the great difference in absenteeism between the
study group (high absenteeism) and the reference population
(low absenteeism), it can bemisleading to compare changes—
in absolute values—over time between the two groups. A
small percentage change in absenteeism in either group would
generate large changes in the absolute difference between the
groups. A solution to this problem is to use the relative chang-
es in absenteeism over time, as in the present study. The results
show that the ratio of absenteeism between the patient cohort
and the reference population remained constant throughout
the study period. The groups followed the same pattern, albeit
at different levels. Higher absenteeism among women is not
unique for this patient group and is true for total sickness
absenteeism in Sweden [13, 15]. Our data thus indicate that
the patient group followed the national trend in sickness ab-
senteeism both pre- and postoperatively, i.e., surgery did not
alter the pattern. Our results are not quite compatible with the
report by Neovius et al. [20] who found that operated patients
had higher direct costs in that they consumed more hospital
days the first years after surgery compared with control sub-
jects. This difference disappeared after 7 years in a 20-year
follow-up study. Their study was however based on a patient
material comprising only 13% gastric bypass patients and they
did not study sick leave.
A limitation of the present study is the lack of information
on body weight in the reference population. The study was
however focused on the possible differences between pre- and
postoperative absenteeism, with the reference population il-
lustrating societal changes. Another possible shortcoming is
that no data were available on whether patients in the operated
group had indeed been admitted to hospital or operated after
the index operation, but without ensuing absenteeism. Also,
short-term absenteeism, 1–2 weeks, cannot be identified using
the national insurance database. The focus of the study was
however societal cost for absenteeism and that could be fully
accounted for, regardless of reason, so that all health conse-
quences resulting in lost work capacity extending for more
than a 2-week period were captured.
One interpretation of our results could be that RYGB can
be performed in obese individuals without causing an in-
creased long-term absence from work. The alternative
interpretation is that the potential health benefits did not out-
weigh the postoperative complications, since RYGB did not
lead to a decrease in work absenteeism. This latter is compat-
ible with previous studies showing no shifts in employment
rate after RYGB surgery [16] and no effects on the rate of
disability pension [17]. This development proved however
to be the case even for diabetics in our material, where patients
with preoperative diabetes had an elevated absenteeism com-
pared to patients without diabetes. After surgery, patients with
diabetes resolution did not deviate towards the patient group
without comorbidity, but remained in parallel to diabetic pa-
tients without resolution. This observation was unexpected
and further strengthens the hypothesis that factors other than
medical care are important for indirect costs to society after
gastric bypass surgery. The paradox of reduced mortality after
RYGB in patients with diabetes [6] and no reduction in ab-
senteeism in the present study remains to be explained.
In summary, the benefits derived from bariatric surgery do
not carry over to a reduction in absenteeism, but can be ob-
tained without increasing such societal costs. Also, the post-
operative absenteeism pattern of preoperative diabetic patients
seems to be governed by factors other than diabetes
resolution.
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